GET DAILY SIGNALSFXG vs RSPS: Comparing Two Distinct Approaches to Consumer Staples Exposure
Key Takeaways
- Different weighting philosophies: FXG uses a multi-factor AlphaDEX selection model, while RSPS equal-weights S&P 500 consumer staples constituents.
- Cost gap: RSPS charges a 0.40% expense ratio, notably cheaper than FXG's 0.63%.
- Exposure purity: FXG drifts into healthcare and consumer cyclical names, whereas RSPS remains nearly fully invested in consumer staples.
- Diversification profile: RSPS caps every holding near 3%, reducing single-name concentration relative to FXG's factor-driven tilts.
- Risk and volatility: Both funds carry low betas, but FXG's mid-cap factor exposure introduces a different risk profile.
- Tickeron AI Verdict: RSPS is favored for its lower cost, purer sector exposure, and more evenly diversified portfolio.
Why These Two ETFs Stand Out
Consumer staples are often viewed as a straightforward defensive allocation, yet two funds targeting the same broad sector can deliver noticeably different results. FXG and RSPS both aim to provide defensive, dividend-oriented equity exposure, but they follow contrasting index-construction methods. One relies on a quantitative factor screen intended to uncover potential outperformance, while the other applies straightforward equal weighting across S&P 500 staples names. For investors considering sector exposure, these structural details matter more than short-term price movements. I also checked this using Tickeron’s AI Screener to see how the two funds compare on key metrics.
First Trust Consumer Staples AlphaDEX Fund (FXG) Overview
FXG tracks the StrataQuant Consumer Staples Index, which applies First Trust's AlphaDEX methodology to select and rank stocks from the Russell 1000 consumer staples universe. The process blends growth and value factors to tilt toward names the model anticipates will outperform. Launched in May 2007, the fund holds roughly 41 securities and carries a 0.63% expense ratio. Because the index re-ranks periodically, the portfolio can extend beyond traditional staples. Recent top holdings include BG, MCK, SFD, PPC, and GIS. Sector allocation sits near 79% consumer defensive, with about 13% in healthcare and smaller positions in consumer cyclical and industrial names. Large-caps account for roughly half the assets, with a notable mid-cap component.
Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) Overview
RSPS follows the S&P 500 Equal Weight Consumer Staples Index, assigning roughly equal weights to every consumer staples constituent of the S&P 500 and rebalancing quarterly. Launched in November 2006, the fund holds about 39 stocks and charges a 0.40% expense ratio. Equal weighting limits dominance by mega-cap names and gives mid-sized staples companies more proportional influence. Recent top holdings include MNST, TGT, KR, COST, and WMT, each typically near 3% of assets. The portfolio stays almost entirely in consumer staples—over 90%—with minimal spillover into cyclicals and a large-cap focus that delivers a cleaner sector allocation.
The Broader Consumer Staples Landscape
Consumer staples operate amid several macro pressures. Ongoing inflation and higher borrowing costs have strained household budgets, pushing shoppers toward value options and pressuring premium brands. At the same time, the sector’s low-beta and cash-generative qualities draw investors seeking stability amid equity volatility. Longer-term factors such as GLP-1 weight-loss drugs, changing consumption habits, and private-label competition pose structural challenges to packaged-food and beverage companies. In this environment, differences in portfolio construction can influence outcomes as much as the sector choice itself.
Performance and Positioning Comparison
Over recent market cycles, the funds have diverged in line with their construction approaches. RSPS’s equal-weight, staples-only design has generally followed the sector’s defensive rotation more closely, aided by quarterly rebalancing that trims winners and adds to laggards. FXG’s factor screen introduces additional style exposure through its healthcare and mid-cap tilt, so performance can reflect earnings trends outside core staples. FXG’s lower beta and value tilt can provide support in risk-off periods, yet its higher fee and less-pure sector profile add uncertainty to relative results. The cost difference tends to favor RSPS over longer holding periods.
Using Tickeron Tools in My Analysis
When comparing sector ETFs like these, I find Tickeron’s AI Screener helpful for quickly scanning holdings, volatility metrics, and performance patterns across similar funds. It lets me apply customizable filters to highlight how construction differences show up in real time, which adds useful context to the structural review above.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
FXG in upward trend: 10-day moving average moved above 50-day moving average on October 28, 2026
The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FXG's RSI Oscillator exited the oversold zone, 19 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for FXG just turned positive on October 06, 2026. Looking at past instances where FXG's MACD turned positive, the stock continued to rise in 37 of 47 cases over the following month. The odds of a continued upward trend are 79%.
FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 259 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 181 of 273 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FXG as a result. In 74 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
The 50-day moving average for FXG moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
FXG broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Category ConsumerStaples
Advertisement